Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cost a Factor in Breast Cancer Treatment Decisions

Publish date:: August 15, 2019

Key clinical point: Treatment costs are a significant influence on decision making on breast cancer treatment.

Major finding: Nearly half of women undergoing breast cancer treatment say cost is a factor when making decisions about treatment.

Study details: A survey of 607 women with a history of breast cancer.

Disclosures: The study was supported by the National Institutes of Health and the Duke Cancer Institute. Six authors reported honoraria, research funding, prior employment and other support from the pharmaceutical sector.

Citation:

Greenup RA et al. J Oncol Pract. 2019 Jul 29. doi: 10.1200/JOP.18.00796.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Breast Cancer

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Study: Doctors underreport side effects of breast irradiation,

No edge for anastrozole over tamoxifen in DCIS,

Long-term APBI cosmetic, toxicity data reported WBI has the edge Practice-confirming results,

Omitting postop radiotherapy doesn’t affect survival in older breast cancer patients,